Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Serra

Showing results (41-50 of 154) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Prognostic value of CCN3 in osteosarcomaBernard Perbal, Monia Zuntini, Diana Zambelli, et al.
International Journal of Molecular Sciences|October 14, 2022
Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation SequencingClaudia Maria Hattinger, Chiara Casotti, Maria Pia Patrizio, et al.
International Journal of Oncology|November 24, 2012
A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cellsMarika A Russo, Mayra Paolillo, Yuly Sanchez-Hernandez, et al.
Chemmedchem|June 15, 2010
A combined high-resolution mass spectrometric and in silico approach for the characterisation of small ligands of beta2-microglobulinLuca Regazzoni, Laura Bertoletti, Giulio Vistoli, et al.
Journal of Chromatography. A|July 4, 2012
Experimental design applied to the optimization of microwave-assisted DNA hydrolysisGiorgio Marrubini, Paolo Fattorini, Carlo Previderé, et al.
Genes, Chromosomes & Cancer|March 26, 2014
Copy number alterations and neoplasia-specific mutations in MELK, PDCD1LG2, TLN1, and PAX5 at 9p in different neoplasiasVirinder Kaur Sarhadi, Leo Lahti, Ilari Scheinin, et al.
Current Cancer Drug Targets|November 10, 2015
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in OsteosarcomaMarilù Fanelli, Claudia Maria Hattinger, Serena Vella, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 7, 2024
Rational Design of Highly Selective Sialyllactose-Imprinted NanogelsCecilia Contardi, Liliia Mavliutova, Massimo Serra, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2006
Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistryMaija Tarkkanen, Marcelo L Larramendy, Tom Böhling, et al.
Cancer Research|August 15, 2008
Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcomaMichela Pasello, Francesca Michelacci, Isabella Scionti, et al.
Pageof 16

Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Prognostic value of CCN3 in osteosarcomaBernard Perbal, Monia Zuntini, Diana Zambelli, et al.
International Journal of Molecular Sciences|October 14, 2022
Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation SequencingClaudia Maria Hattinger, Chiara Casotti, Maria Pia Patrizio, et al.
International Journal of Oncology|November 24, 2012
A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cellsMarika A Russo, Mayra Paolillo, Yuly Sanchez-Hernandez, et al.
Chemmedchem|June 15, 2010
A combined high-resolution mass spectrometric and in silico approach for the characterisation of small ligands of beta2-microglobulinLuca Regazzoni, Laura Bertoletti, Giulio Vistoli, et al.
Journal of Chromatography. A|July 4, 2012
Experimental design applied to the optimization of microwave-assisted DNA hydrolysisGiorgio Marrubini, Paolo Fattorini, Carlo Previderé, et al.
Genes, Chromosomes & Cancer|March 26, 2014
Copy number alterations and neoplasia-specific mutations in MELK, PDCD1LG2, TLN1, and PAX5 at 9p in different neoplasiasVirinder Kaur Sarhadi, Leo Lahti, Ilari Scheinin, et al.
Current Cancer Drug Targets|November 10, 2015
Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in OsteosarcomaMarilù Fanelli, Claudia Maria Hattinger, Serena Vella, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 7, 2024
Rational Design of Highly Selective Sialyllactose-Imprinted NanogelsCecilia Contardi, Liliia Mavliutova, Massimo Serra, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2006
Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistryMaija Tarkkanen, Marcelo L Larramendy, Tom Böhling, et al.
Cancer Research|August 15, 2008
Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcomaMichela Pasello, Francesca Michelacci, Isabella Scionti, et al.
Pageof 16